高危局限前列腺癌:根治性前列腺切除与外照射联合近距离放疗的疗效比较
基于美国国家癌症数据库,比较≤65岁且Charlson合并症指数为0的高危局限前列腺癌患者接受根治性前列腺切除(RP)与外照射联合近距离放疗(EBRT+BT)的总生存(OS)。中位随访92个月,经逆概率加权Cox回归分析,EBRT+BT的全因死亡风险高于RP(HR=1.22,95%CI 1.05-1.43)。
要点
- 年轻健康高危局限前列腺癌患者中,RP较EBRT+BT显示OS获益。
- EBRT+BT组全因死亡风险较RP组高22%(HR=1.22)。
- 既往研究因随访短和年龄合并症差异未发现OS差异。
核心结论
- 在≤65岁且Charlson合并症指数为0的高危局限前列腺癌患者中,RP较EBRT+BT具有统计学显著的OS获益。
研究设计与样本
- 基于美国国家癌症数据库的回顾性比较研究,纳入≤65岁且Charlson合并症指数为0的高危局限前列腺癌患者,比较RP与EBRT+BT的OS,采用逆概率加权调整基线特征,中位随访92个月(四分位距78-108)。
主要发现
- 经逆概率加权Cox回归分析,EBRT+BT与RP相比全因死亡风险更高(HR=1.22,95%CI 1.05-1.43)。
临床怎么用
- 对于年轻且无合并症的高危局限前列腺癌患者,在与患者讨论初始治疗方案时,可将RP较EBRT+BT的OS获益作为参考信息。
局限性
- 研究为回顾性数据库分析,既往同类研究受随访时间短及年龄和合并症差异限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A previous study comparing external beam radiation therapy with/without brachytherapy (EBRT±BT) and radical prostatectomy (RP) for high-risk localized prostate cancer (PCa) did not find a difference in overall survival (OS) between the treatments. However, this study was limited by short follow-up and assessment of OS in patients of divergent age and comorbidities. We therefore compared OS of EBRT+BT versus RP in comparatively young (≤65yr) and healthy men (Charlson Comorbidity Index=0) with high-risk localized PCa in the National Cancer Database. Inverse probability of treatment weighting (IPTW) adjustment was used to balance baseline characteristics. Median follow-up was 92mo (interquartile range 78-108). Using IPTW-adjusted Cox regression analysis, EBRT+BT was associated with a higher risk of all-cause mortality compared with RP (hazard ratio=1.22, 95% confidence interval 1.05-1.43). In young and healthy men presenting with high-risk localized PCa, RP showed statistically significant OS benefit compared with EBRT+BT. PATIENT SUMMARY: In an analysis restricted to young and healthy men presenting with high-risk localized prostate cancer, initial radical prostatectomy is associated with an overall survival benefit compared with external beam radiation therapy plus brachytherapy.
引用
- Berg S, Cole AP, Krimphove MJ, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol. 2018. PMID: 30420255. doi:10.1016/j.eururo.2018.10.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。